We want to start with the basics about Hormone Replacement Therapy, so you can get up to speed on the importance of MiraKind’s new study. In this article, we’ll cover what Hormone Replacement Therapy is, what we know about it now, and what we don’t know and are hoping to learn more about! So what […]
MiraKind
New Partnership Alert: MiraKind & gennev
MiraKind is committed to providing our community with the best tools possible to tackle challenges in the arena of women’s health. This is why MiraKind is partnering with gennev, a first-of-its-kind telehealth clinic offering expert counsel to women about menopause. Gennev is a growing community of women and practitioners that align with MiraKind’s commitment to […]
More proof Hormone Replacement Therapy (HRT) is safe, effective, and beneficial for most women
When our team came across a recent Los Angeles Times Article entitled, “Once and for all: Hormone replacement is good for women” we were very intrigued. What we learned from this game-changing article brought us into a collaboration with like-minded leaders in the healthcare field who understand the importance of our innovative research that empowers […]
Important Findings From Our Recently Published KRAS-Variant Study
A new study by MiraKind’s Founder, Dr. Joanne Weidhaas, in collaboration with her team at the University of California, Los Angeles and City of Hope, has been published in the scientific journal Death & Differentiation. The study, entitled, “The KRAS-variant and its impact on normal breast epithelial cell biology,” investigated altered normal cellular biology in […]
Turning Knowledge Into Action & Power
Jane* had always followed the medical guidelines, so at age 40, she started her annual mammogram screenings. In March of 2009, right before her 57th birthday, Jane went in for what she thought was just another routine screening. In this screening, a small tumor was detected in her breast tissue. After a biopsy following the […]
Connecting a Family History of Cancer with Personal Health
Jenn Roark was only 33 when she was first diagnosed with Invasive Ductal Breast Cancer. She felt a hard spot on her breast, short of a lump, but decided to be safe and go to her OBGYN to discuss it further. Her OBGYN referred her to a Breast Care Clinic and on October 31st, 2008, […]
If I participate in a study will you send me my KRAS-variant results?
We had an excellent question from a MiraKind study participant. They wanted to know, “If I participate in a study will you send me my KRAS-variant results?” Unfortunately, the answer is no. You actually need to apply to give us permission to send the result through MiraDX. This is a CLIA lab and allows us […]
Do I need to get tested for KRAS-variant if I’m BRCA positive?
We received a great question from a friend of a patient asking, “since she knows she has a BRCA mutation, is it necessary to find out if she also has the KRAS-variant? Would it change her cancer prevention strategies?” No, it’s not necessary. Management for BRCA mutant patients is very well established and having the […]
Should I Get Pelvic Exams if I Have No Ovaries?
We had an excellent question from a participant who has the KRAS-variant and had chosen to have her ovaries removed. She asked her OB/GYN if she still needed to have pelvic exams since she no longer had ovaries. She was told she did not. I checked that fact with other experts in the field and […]
How Genetic Testing Helped Karen Navigate Her Cancer Treatment
When pathology reports from her lung cancer biopsy showed that 56-year-old Karen Peterson was positive for the KRAS oncogene, she had never heard of the KRAS protein before. Karen and her family turned to the internet, hoping to learn more about the gene’s influence on Karen’s lung cancer diagnosis. Back in 2016, the same evening […]
New Research: “The KRAS-variant induces an epithelial-to-mesenchymal transition ‘EMT’ in normal breast epithelial cells”
As discussed in our previous Genetics series posts, the discovery of non-coding RNAs paved the way for changes in the Central Dogma and how we think about the flow of genetic information in our cells. The KRAS-variant is important because it interacts with a specific class of these non-coding RNAs, called microRNAs. Take a look […]
KRAS-Variant and Breast Cancer
Webinar – KRAS-Variant and Breast Cancer Did you miss our live webinar on the KRAS-Variant with Dr. Joanne Weidhaas? Watch the replay and learn about how this genetic mutation can impact your cancer risk and treatment. | Rethink Breast Cancer | Breast Cancer Awareness | National Breast Cancer Foundation | Posted by Mirakind on Friday, […]
